Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04267874 · ClinicalTrials.gov registry record · Early Phase 1
Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study
A Early Phase 1 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 96
- Enrollment target
NCT04267874 is a Early Phase 1 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 96 participants.
The verdict
NCT04267874, a Early Phase 1 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 96 participants
- Enrollment target
Study Summary
This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- DRUG Placebo Administration
- DIETARY_SUPPLEMENT Nutritional Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2021-06-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04267874
The ClinicalTrials.gov registry entry for NCT04267874 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT04267874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04267874 about?
NCT04267874 is a clinical study titled "Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study". This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.
What is the current status of trial NCT04267874?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 96 participants. The study started on 2019-10-25. Estimated completion is 2021-06-13.
What interventions are being tested in trial NCT04267874?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Placebo Administration (DRUG), Nutritional Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04267874?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.